Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Studienzentrum Dr. Braun GmbH

Research site

Germany Breite Str. 41, 13187 Berlin, Germany

  • Arteriosclerosis · COVID-19 immunisation · Clinical trial participant
  • Adult patients

About Specializations

Studienzentrum Dr. Braun GmbH in Berlin, Germany specialises in clinical trials of conditions such as Arteriosclerosis, COVID-19 immunisation, Clinical trial participant, Immunisation, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Disease Research

The Cardiovascular Diseases program at Studienzentrum Dr. Braun focuses on patients with atherosclerotic cardiovascular disease and obesity, aiming to assess a new therapy’s ability to lower cardiovascular morbidity and mortality when added to existing treatment.

  • Atherosclerotic cardiovascular disease (ASCVD) and overweight
  • Evaluation of a GLP‑1 analogue for heart‑related outcomes
  • Integration of weight management into cardiovascular care

This research supports improved long‑term heart health for adults in Berlin and contributes to broader European cardiovascular strategies.

Viral Infection Research

The site’s Virus Diseases portfolio investigates immune responses to a combined SARS‑CoV‑2 and high‑dose influenza vaccine in adults aged 60 and older, seeking to confirm comparable protection across both viruses.

  • COVID‑19 (SARS‑CoV‑2) vaccine immunogenicity
  • Influenza vaccine strain‑specific immunity
  • Safety and efficacy of co‑administration in seniors

Findings aim to simplify vaccination schedules for older populations and enhance public health preparedness throughout Europe.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Breite Str. 4113187 BerlinGermany
Open in maps ↗
Recruiting now
no trials
Conditions studied
5

More sites in BerlinGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Immunisation+3

Not yet recruiting

SARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
  • Sponsor:Sanofi Vaccines US Inc.

Arteriosclerosis

Not recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.